167 related articles for article (PubMed ID: 18037657)
1. Healing cranial defects with AdRunx2-transduced marrow stromal cells.
Zhao Z; Wang Z; Ge C; Krebsbach P; Franceschi RT
J Dent Res; 2007 Dec; 86(12):1207-11. PubMed ID: 18037657
[TBL] [Abstract][Full Text] [Related]
2. Gene transfer of the Runx2 transcription factor enhances osteogenic activity of bone marrow stromal cells in vitro and in vivo.
Zhao Z; Zhao M; Xiao G; Franceschi RT
Mol Ther; 2005 Aug; 12(2):247-53. PubMed ID: 16043096
[TBL] [Abstract][Full Text] [Related]
3. Cbfa1/osf2 transduced bone marrow stromal cells facilitate bone formation in vitro and in vivo.
Zheng H; Guo Z; Ma Q; Jia H; Dang G
Calcif Tissue Int; 2004 Feb; 74(2):194-203. PubMed ID: 14595529
[TBL] [Abstract][Full Text] [Related]
4. Marrow stromal cell-based cyclooxygenase 2 ex vivo gene-transfer strategy surprisingly lacks bone-regeneration effects and suppresses the bone-regeneration action of bone morphogenetic protein 4 in a mouse critical-sized calvarial defect model.
Lau KH; Gysin R; Chen ST; Wergedal JE; Baylink DJ; Mohan S
Calcif Tissue Int; 2009 Oct; 85(4):356-67. PubMed ID: 19763374
[TBL] [Abstract][Full Text] [Related]
5. Cellular hypoxia promotes osteogenic differentiation of mesenchymal stem cells and bone defect healing via STAT3 signaling.
Yu X; Wan Q; Ye X; Cheng Y; Pathak JL; Li Z
Cell Mol Biol Lett; 2019; 24():64. PubMed ID: 31827540
[TBL] [Abstract][Full Text] [Related]
6. Lentiviral-mediated expression of SATB2 promotes osteogenic differentiation of bone marrow stromal cells in vitro and in vivo.
Gong Y; Qian Y; Yang F; Wang H; Yu Y
Eur J Oral Sci; 2014 Jun; 122(3):190-7. PubMed ID: 24666017
[TBL] [Abstract][Full Text] [Related]
7. Conditioned medium from bone marrow mesenchymal stem cells transiently retards osteoblast differentiation by downregulating runx2.
Sun J; Zhou H; Deng Y; Zhang Y; Gu P; Ge S; Fan X
Cells Tissues Organs; 2012; 196(6):510-22. PubMed ID: 22906827
[TBL] [Abstract][Full Text] [Related]
8. Gene therapy approaches for bone regeneration.
Franceschi RT; Yang S; Rutherford RB; Krebsbach PH; Zhao M; Wang D
Cells Tissues Organs; 2004; 176(1-3):95-108. PubMed ID: 14745239
[TBL] [Abstract][Full Text] [Related]
9. Bone regeneration using an acellular extracellular matrix and bone marrow mesenchymal stem cells expressing Cbfa1.
Dong SW; Ying DJ; Duan XJ; Xie Z; Yu ZJ; Zhu CH; Yang B; Sun JS
Biosci Biotechnol Biochem; 2009 Oct; 73(10):2226-33. PubMed ID: 19809195
[TBL] [Abstract][Full Text] [Related]
10. p53 deficiency promotes bone regeneration by functional regulation of mesenchymal stromal cells and osteoblasts.
Nagashima T; Ninomiya T; Nakamura Y; Nishimura S; Ohashi A; Aoki J; Mizoguchi T; Tonogi M; Takahashi T
J Bone Miner Metab; 2022 May; 40(3):434-447. PubMed ID: 35195777
[TBL] [Abstract][Full Text] [Related]
11. Targeted reversion of induced pluripotent stem cells from patients with human cleidocranial dysplasia improves bone regeneration in a rat calvarial bone defect model.
Saito A; Ooki A; Nakamura T; Onodera S; Hayashi K; Hasegawa D; Okudaira T; Watanabe K; Kato H; Onda T; Watanabe A; Kosaki K; Nishimura K; Ohtaka M; Nakanishi M; Sakamoto T; Yamaguchi A; Sueishi K; Azuma T
Stem Cell Res Ther; 2018 Jan; 9(1):12. PubMed ID: 29357927
[TBL] [Abstract][Full Text] [Related]
12. Exogenous Runx2 expression enhances in vitro osteoblastic differentiation and mineralization in primary bone marrow stromal cells.
Byers BA; García AJ
Tissue Eng; 2004; 10(11-12):1623-32. PubMed ID: 15684671
[TBL] [Abstract][Full Text] [Related]
13. Efficient osteoblast differentiation from mouse bone marrow stromal cells with polylysin-modified adenovirus vectors.
Tashiro K; Kondo A; Kawabata K; Sakurai H; Sakurai F; Yamanishi K; Hayakawa T; Mizuguchi H
Biochem Biophys Res Commun; 2009 Jan; 379(1):127-32. PubMed ID: 19103162
[TBL] [Abstract][Full Text] [Related]
14. Bortezomib enhances the osteogenic differentiation capacity of human mesenchymal stromal cells derived from bone marrow and placental tissues.
Sanvoranart T; Supokawej A; Kheolamai P; U-Pratya Y; Klincumhom N; Manochantr S; Wattanapanitch M; Issaragrisil S
Biochem Biophys Res Commun; 2014 May; 447(4):580-5. PubMed ID: 24747566
[TBL] [Abstract][Full Text] [Related]
15. Combinatorial gene therapy with BMP2/7 enhances cranial bone regeneration.
Koh JT; Zhao Z; Wang Z; Lewis IS; Krebsbach PH; Franceschi RT
J Dent Res; 2008 Sep; 87(9):845-9. PubMed ID: 18719211
[TBL] [Abstract][Full Text] [Related]
16. The effect of autologous bone marrow stromal cells differentiated on scaffolds for canine tibial bone reconstruction.
Özdal-Kurt F; Tuğlu I; Vatansever HS; Tong S; Deliloğlu-Gürhan SI
Biotech Histochem; 2015; 90(7):516-28. PubMed ID: 25994048
[TBL] [Abstract][Full Text] [Related]
17. Effects of Runx2 genetic engineering and in vitro maturation of tissue-engineered constructs on the repair of critical size bone defects.
Byers BA; Guldberg RE; Hutmacher DW; García AJ
J Biomed Mater Res A; 2006 Mar; 76(3):646-55. PubMed ID: 16287095
[TBL] [Abstract][Full Text] [Related]
18. The interferon-inducible protein p202 promotes osteogenesis in mouse bone marrow stromal cells.
Zhang L; Wang C; Zhang X; Li H
Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29853536
[TBL] [Abstract][Full Text] [Related]
19. Preameloblast-Derived Factors Mediate Osteoblast Differentiation of Human Bone Marrow Mesenchymal Stem Cells by Runx2-Osterix-BSP Signaling.
Choung HW; Lee DS; Lee HK; Shon WJ; Park JC
Tissue Eng Part A; 2016 Jan; 22(1-2):93-102. PubMed ID: 26413977
[TBL] [Abstract][Full Text] [Related]
20. The effect of the cleidocranial dysplasia-related novel 1116_1119insC mutation in the RUNX2 gene on the biological function of mesenchymal cells.
Ding B; Li C; Xuan K; Liu N; Tang L; Liu Y; Guo W; Liu W; Jin Y
Eur J Med Genet; 2013 Apr; 56(4):180-7. PubMed ID: 23376464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
